Terns Pharmaceuticals

IPO

Home - Terns Pharma

Public · Foster City, United States · Founded 2016 · $167.0M raised

Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$167.0M
Last Round
$87.0M Series CJan 2021
Rounds
2
Type
Public

About

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies for metabolic diseases, including obesity, MASH (metabolic dysfunction-associated steatohepatitis), and related conditions. Founded in 2016, the company's pipeline includes THR-β agonist, GLP-1 receptor agonist, and other complementary mechanisms targeting cardio-metabolic disease.

Summary

Terns Pharmaceuticals is a Biotech company based in Foster City, United States, founded in 2016. It has raised $167.0M in total across 2 rounds, most recently a $87.0M Series C round in Jan 2021. Investors include Deerfield Management, Vivo Capital and OrbiMed.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Secondary MarketSecondary MarketDec 2025

Sign up to see all 4 rounds

Series B through Secondary Market — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Terns Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/terns-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/terns-pharmaceuticals" alt="Terns Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>